Pfizer 4Q Revenues: $13.6 billion (-3%) 4Q Earnings: $775 million (loss of $172 million 4Q15) FY Revenues: $52.8 billion (+8%) FY Earnings: $7.2 billion (+4%) Comments: Innovative Health sales were $29.2 billion for the year, up 9%. Essential health sales were $23.6 billion, up 7%. Lyrica sales were $4.2 billion, up 14% for the year. Viagra sales were $1.2 billion, down 9%. Chantix sales were $842 million, up 26%. Loss of exclusivity for Prevnar 13 Adult impacted sales in the U.S....